Is Compounded PT-141 (Bremelanotide) Safe and Legal?
Compounded PT-141 (Bremelanotide) is not currently available through Compounding Finder. PT-141 / bremelanotide is not on the FDA 503A bulk substances list for generic compounding. The brand-name product Vyleesi is FDA-approved for a specific indication — talk to your prescriber about whether that is an option.
Read the PT-141 (Bremelanotide) background guide →The Short Answer
Under Section 503A of the Federal Food, Drug, and Cosmetic Act, US compounding pharmacies can only compound from FDA-approved active ingredients, substances with a USP or NF monograph, or substances on the FDA 503A bulk substances list. PT-141 (Bremelanotide) does not meet any of these criteria, so a licensed US compounding pharmacy cannot legally prepare or dispense it for human consumption — even with a prescription. Products marketed as PT-141 (Bremelanotide) outside this framework generally come from research-chemical suppliers and are not regulated for human use.
Who Is Eligible for Compounded PT-141 (Bremelanotide)?
- There is no clinical eligibility pathway for PT-141 (Bremelanotide) through 503A compounding at this time.
- If your prescriber has recommended PT-141 (Bremelanotide), ask about FDA-approved alternatives that address the same condition.
- If FDA guidance changes and PT-141 (Bremelanotide) is added to the 503A bulks list in the future, Compounding Finder will revisit routing.
Safety Considerations
- Only purchase prescription medications from U.S.-licensed compounding pharmacies for medications that are legally compoundable.
- Research-chemical peptide vendors and overseas "pharmacies" selling PT-141 (Bremelanotide) for human use are not regulated — product identity, purity, sterility, and dosing are not verified.
- Any provider willing to prescribe or source a non-compoundable substance through these channels is operating outside the US 503A framework.
Red Flags: What to Avoid
- Any online clinic, telehealth provider, or vendor offering to "compound" or ship PT-141 (Bremelanotide) for human use.
- Labeling that calls a product "research use only" or "not for human consumption" while simultaneously marketing it for human indications.
- Pharmacies that fulfill a prescription for an ingredient not on the FDA 503A bulks list — they are operating outside federal rules.
Frequently Asked Questions
Can any US compounding pharmacy prepare PT-141 (Bremelanotide) for me?
No. PT-141 (Bremelanotide) is not FDA-approved and is not on the FDA 503A bulk substances list. Licensed US 503A pharmacies are only permitted to compound from FDA-approved APIs, USP/NF monograph substances, or substances on the 503A bulks list. A prescription for PT-141 (Bremelanotide) cannot be legally filled by a 503A pharmacy regardless of what the prescription says.
Why is Compounding Finder not sending PT-141 (Bremelanotide) quote requests to pharmacies?
We only refer patients to licensed US 503A pharmacies. Sending a PT-141 (Bremelanotide) quote request to those pharmacies would put them in a position to either decline or to fill a prescription they are not legally permitted to fill. Neither outcome is useful to the patient, so we do not route these requests.
What should I do if my prescriber recommended this?
Ask them whether an FDA-approved medication addresses the same underlying condition — for many of these peptides there are FDA-approved alternatives worth discussing. If the recommendation came from a wellness or telehealth clinic that also sells the product, be skeptical; that is not the same regulatory channel as a licensed US 503A compounding pharmacy.
Keep Reading
Pharmacy basics: 503A vs 503B pharmacies — what's the difference? →
Vetting pharmacies: How to find a reputable compounding pharmacy →
Overview: Compounded PT-141 (Bremelanotide) — overview & pricing →
Compare prices: Compare PT-141 (Bremelanotide) pricing from licensed pharmacies →
We Do Not Currently Route PT-141 (Bremelanotide) Quote Requests
Because of the FDA’s current stance on PT-141 (Bremelanotide), Compounding Finder is not sending PT-141 (Bremelanotide) quote requests to our pharmacy network at this time. If FDA guidance changes, we will revisit.